| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |